¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"È¿"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • concentration effect
    ³óµµÈ¿°ú
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • carboxyltransferase
    Ä«¸£º¹½ÇÀü´ÞÈ¿¼Ò
  • carboxypeptidase
    Ä«¸£º¹½ÃÆéƼµåºÐÇØÈ¿¼Ò
  • convertase
    Àüȯȿ¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • cost-effectiveness analysis
    ºñ¿ëÈ¿°úºÐ¼®
  • cost-efficiency analysis
    ºñ¿ëÈ¿À²ºÐ¼®
  • cost-utility analysis
    ºñ¿ëÈ¿¿ëºÐ¼®
  • CPK
    Å©·¹¾ÆÆ¾ÀλêȰ¼ºÈ¿¼Ò
  • creatine kinase isoenzymes
    Å©·¹¾ÆÆ¾Å°³ª¾ÆÁ¦µ¿Á¾È¿¼Ò
  • creatine phosphokinase
    Å©·¹¾ÆÆ¾ÀλêȰ¼ºÈ¿¼Ò
  • cumulative effect
    ´©ÀûÈ¿°ú, ÃàÀûÈ¿°ú
  • curative effect
    Ä¡·áÈ¿°ú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • alkaline phosphatase
    ¾ËÄ®¸®ÀλêºÐÇØÈ¿¼Ò
  • high potency
    °íÈ¿´É, °í¿ª°¡, °íÀáÀç·Â
  • low potency
    ÀúÈ¿´É, Àú¿ª°¡, ÀúÀáÀç·Â
  • RI
    (¢¡ regular insulin) ¼ÓÈ¿Àν¶¸°, ºü¸¥ÀÛ¿ëÀν¶¸°
  • ribonuclease
    ¸®º¸ÇÙ»êºÐÇØÈ¿¼Ò
  • reducase
    ȯ¿øÈ¿¼Ò
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
  • synthetase
    ÇÕ¼ºÈ¿¼Ò
  • physiologic dead space
    »ý¸®¹«È¿°ø°£
  • topoisomerase
    ±¹¼ÒÀ̼ºÈ­È¿¼Ò
  • thromboplastinase
    Æ®·Òº¸ÇÃ¶ó½ºÆ¾ºÐÇØÈ¿¼Ò
  • transferase
    ÀüÀÌÈ¿¼Ò
  • transaminase
    ¾Æ¹Ì³ëÀüÀÌÈ¿¼Ò
  • transcriptase
    Àü»çÈ¿¼Ò
  • telomerase
    ³¡ºÐÀýÈ¿¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • cavitation effect
    °øµ¿È¿°ú
  • ceiling effect
    ÃÖ°íÈ¿°ú
  • clasp-knife effect
    Á¢´ÂĮȿ°ú
  • clinical efficacy
    ÀÓ»óÈ¿´É
  • coagulase test
    Ç÷ÀåÀÀ°íÈ¿¼Ò°Ë»ç
  • cohort effect
    ÄÚȣƮȿ°ú
  • collection efficiency
    ¼öÁýÈ¿À²
  • collective effective dose
    Áý´ÜÀ¯È¿¼±·®
  • combined effect
    º´¿ëÈ¿°ú
  • combustion efficiency
    ¿¬¼ÒÈ¿À²
  • committed effective dose
    ¿¹Å¹À¯È¿¼±·®
  • concentration effect
    ³óµµÈ¿°ú
  • constitutive enzyme
    ±âº»±¸¼ºÈ¿¼Ò
  • converting enzyme inhibitor
    Àüȯȿ¼Ò¾ïÁ¦Á¦
  • crude efficiency
    Á¶È¿À²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Glycerol ester hydrolase
    ±Û¸®¼¼·Ñ ¿¡½ºÅÍ °¡¼öºÐÇØÈ¿¼Ò(Ê¥â©ÝÂú°ý£áÈ)
  • Glycolytic enzymes
    ÇØ´çÈ¿¼Ò(ú°ÓØý£áÈ)
  • GnRH agonist
    ¼º¼±ÀÚ±ØÈ£¸£¸ó À¯¸® È£¸£¸ó È¿´É¾à
  • H+-K+ ATPase
    ¼ö¼Ò-Ä®·ý ¾Æµ¥³ë½Å»ïÀλêÈ¿¼Ò
  • HIV effect
    HIV È¿°ú<ÀÛ¿ë>
  • Haldane effect
    ÇÒµ§È¿°ú
  • Hemopexin
    Çì¸ðÆå½Å, ÀÀÇ÷È¿¼Ò(ëêúìý£áÈ)
  • Hydrogen-ATP ase mechanism
    ¼ö¼Ò-¾Æµ¥³ë½Å»ïÀλêÈ¿¼Ò ±âÀÛ
  • Hydroxymethylglutary-CoA
    ÇÏÀ̵å·Ï½Ç±Û·çŸ¸°-º¸Á¶È¿¼ÒA
  • Intestinal mucosa, digestive enzymes
    Àå°üÁ¡¸·(íóηïÄØ¯), ¼ÒÈ­È¿¼Ò(á¼ûùý£áÈ)
  • Kovacs oxidase reagent
    Äڹ齺 »êÈ­È¿¼Ò°Ë»ç½Ã¾à
  • LDH = lactic dehydrogenase
    Á¥»ê(¡­ß«) Å»¼ö¼ÒÈ¿¼Ò(÷­â©áÈý£áÈ)
  • LDH= lactic dehydrogenase
    ¶ôÆ®»êÅ»¼ö¼ÒÈ¿¼Ò.
  • Lactase
    ¶ôÅ×ÀÌÁî, À¯´çºÐÇØÈ¿¼Ò(êáÓØÝÂú°ý£áÈ)
  • Lactic acid dehydrogenase
    ¶ôÆ® »êÅ»¼ö¼ÒÈ¿¼Ò(¡­ß«÷­â©áÈý£áÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • assay, enzyme-linked immuno(ad)sorbent (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme immunoassay (EIA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme linked immunosorbent assay (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme-linked immunosorbent assay
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzymatic zonulysis
    È¿¼Ò¸ð¾çü¼Ò´ëºÐÇØ
  • zymogenesis
    È¿¼Ò¹ß»ý(ý£áÈÛ¡ßæ).
  • zymoplastic
    È¿¼Ò¹ß»ýÀÇ.
  • zymotic disease
    È¿¼Òº´(ý£áÈÜ»)
  • zymotic disease
    È¿¼Òº´(ý£áÈÜ»).
  • enzymopathy
    È¿¼Òº´Áõ.
  • enzymosis
    È¿¼Ò¼º ¹ßÈ¿.
  • fat necrosis,enzymatic
    È¿¼Ò¼º(ý£áÈàõ)
  • enzymatic assay
    È¿¼Ò¼º(ý£áÈàõ) ÃøÁ¤(ö´ïÒ)(¹ý).
  • enzymatic debridement
    È¿¼Ò¼ÒÁ¦¹ý
  • enzymatic assay
    È¿¼Ò¾Æ½êÀ̼º ÃøÁ¤(¹ý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • assay
    Á¤·®, ¿ª°¡°ËÁ¤, È¿·Â°ËÁ¤
  • assay, enzyme-linked immuno(ad)sorbent (ELISA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • aural microphonics
    ÀÌÈ®¼ºÈ¿°ú
  • autofermentation
    ÀÚ°¡¹ßÈ¿.
  • autolytic enzyme
    ÀÚ±âÀ¶ÇØÈ¿¼Ò(¡­ë×ú° ý£áÈ).
  • autolytic enzyme
    ÀÚ°¡¿ëÇØÈ¿¼Ò
  • available
    °¡¿ëÀÇ, À¯È¿ÀÇ.
  • available chlorine
    À¯È¿¿°¼Ò(ËôÌ·ËçËÛ).
  • available phosphoric acid
    À¯È¿Àλê.
  • available water
    À¯È¿¼ö(êóüùâ©).
  • azymia
    ¹«È¿¼Ò(Ùíý£áÈ), È¿¼Ò°á¿©(¡­ÌÀåý).
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú ¡ìÆóÁ¤¸Æ¿ïÇ÷¡í.»ý¸®ÈĹæ¾Ð·ÂÀÛ¿ë(ý­Û°äâæ³íÂéÄ).
  • bacteriostatic effect
    Á¤±ÕÈ¿°ú(¡­üùÍý).
  • beam hardening (effect)
    ºö°æÈ­È¿°ú
  • beam softening (effect)
    ºö¿¬È­È¿°ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • converter enzyme
    Àüȯȿ¼Ò(ï®üµý£áÈ)
  • converting enzyme
    "Àüȯ È¿¼Ò(ï®üµý£áÈ), (ÔÒ) serum converting enzyme"
  • coordinated enzyme
    µ¿Á¶È¿¼Ò(ÔÒðàý£áÈ)
  • coordinated enzyme synthesis
    µ¿Á¶È¿¼ÒÇÕ¼º(ÔÒðàý£áÈùêà÷)
  • core enzyme
    ÇÙ½ÉÈ¿¼Ò(ú·ãýý£áÈ)
  • Cotton effect
    ÄÚÅæ È¿°ú(üùÍý)
  • Coulomb effect
    "Äí·Õ È¿°ú(üùÍý),(ÔÒ) ion-ion interaction"
  • counting efficiency
    °èÃø È¿À²(ͪö´üù×Ë)
  • Crabtree effect
    Å©·¡ºêÆ®¸® È¿°ú(üùÍý)
  • cryoenzymology
    Àú¿ÂÈ¿¼ÒÇÐ(î¸è®ý£áÈùÊ)
  • debranching enzyme
    °¡ÁöÁ¦°Å(ð¶ËÛ) È¿¼Ò(ý£áÈ)
  • depolymerizing enzyme
    ÇØÁßÇÕ È¿¼Ò(ú°ñìùêý£áÈ)
  • desensitized enzyme
    Å»°¨ÀÛÈ¿¼Ò(÷­ÊõíÂý£áÈ)
  • desmoenzyme
    "ºÎÂøÈ¿¼Ò(ݾó·ý£áÈ), (ÔÒ) particulate enzyme"
  • digestive enzyme
    ¼ÒÈ­È¿¼Ò(á¼ûùý£áÈ)
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • R89.0
    Abnormal level of enzymes
    ÀÌ»ó È¿¼Ò ¼öÄ¡
  • T44.4
    Predominantly ¥á-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î ¾ËÆÄ¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
  • T44.5
    Predominantly ¥â-adrenoreceptor agonists, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ÁÖ·Î º£Å¸¾Æµå·¹³¯¸° ¼ö¿ëü È¿´ÉÁ¦
  • T45.3
    Enzymes, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº È¿¼Ò
  • T46.4
    Angiotensin-converting-enzyme inhibitors
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦Á¦
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • desulfhydrase
    ŻȲȭ ¼ö¼Ò È¿¼Ò
    ½Ã½ºÅ×ÀÎÀ» Ȳȭ ¼ö¼Ò, ¾Ï¸ð´Ï¾Æ, ÆÄÀÌ·çºó»êÀ¸·Î ºÐÇØÇÏ´Â È¿¼Ò.
  • dextrase
    µ¦½ºÆ®¶óÁ¦, µ¦½ºÆ®¶õ ºÐÇØ È¿¼Ò
  • dextrinase
    µ¦½ºÆ®¸®³ªÁ¦, µ¦½ºÆ®¸° ºÐÇØ È¿¼Ò
    ÀüºÐÀ» isomaltose·Î Àüȯ½ÃŰ´Â È¿¼Ò.
  • digestive enzyme
    ¼ÒÈ­ È¿¼Ò
  • disaccharidase
    ÀÌ´ç·ù ºÐÇØ È¿¼Ò
    ÀÌ´ç·ù¸¦ °¡¼öºÐÇØÇÏ´Â È¿¼Ò.
  • DNase test
    DNA ºÐÇØ È¿¼Ò ½ÃÇè
  • domino effect
    µµ¹Ì³ë È¿°ú
  • Donnan effect
    µµ³­ È¿°ú
  • dopamine autoreceptor agonist
    µµÆÄ¹Î ÀÚ°¡ ¼ö¿ëü È¿ÇöÁ¦
  • Doppler effect
    µµÇ÷¯ È¿°ú, Doppler È¿°ú
    1. ±Ù¿øÁö¿¡ ´ëÇÑ ¼ö½ÅÁöÀÇ »ó´ëÀûÀÎ ¿îµ¿À¸·ÎºÎÅÍ ¾ß±âµÇ´Â Á֯ļöÀÇ ¸í¹éÇÑ º¯È­. 2. ¾î¶² ¹°Ã¼°¡ ¿îµ¿ »óÅ¿¡ ÀÖÀ» ¶§ ³ªÅ¸³ª´Â ¹ÝÇâµÇ´Â ¹æ»ç¼±¿¡¼­ Áøµ¿¼öÀÇ º¯È­´Â µµÇ÷¯ È¿°úÀÇ °á°úÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ¸·ÎºÎÅÍ ¶³¾îÁø ¹°Ã¼ÀÇ ¿îµ¿Àº Á¤Áö »óÅÂÀÇ ¹°Ã¼¿¡ ºñ±³ÇØ º¼ ¶§ ´õ ³·Àº Áøµ¿¼öÀÇ ¹ÝÇâÀ» ÀÏÀ¸Å³ °ÍÀÌ´Ù. ¹æ»ç¼±ÀÇ ±Ù¿øÀ» ÇâÇÑ ¿îµ¿Àº ´õ ³ôÀº Áøµ¿¼ö¸¦ ÀÏÀ¸Å²´Ù.
  • dose rate effect
    ¼±·®À² È¿°ú
  • double effect
    ÀÌÁß È¿°ú
  • drug of choice
    ¼±Åà ¾àÁ¦, Ưȿ ¾à
  • effective
    À¯È¿ÇÑ
    ÀǵµµÈ °á°ú¸¦ ÀÏÀ¸Å³ ¼ö ÀÖ´Â.
  • effective arterial volume
    À¯È¿ µ¿¸ÆÇ÷·®
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • RNase
    RN¾ÆÁ¦(¸®º¸ÇÙ»êºÐÇØÈ¿¼Ò)
  • Raman effect
    ¶ó¸¸ È¿°ú(ºûÀÌ Åõ¸íÇÑ ¸ÅÁúÀ» Åë°úÇÒ ¶§,»ê¶õÇÏ¿© ºûÀÇ ÀϺΠÆÄÀåÀÌ º¯È­ÇÏ´Â Çö»ó)
  • Seidlitz
    ¼¼µé¸®Ã÷»ê(¾àÈ¿°¡ üÄÚ½½·Î¹ÙŰ¾Æ Seidlitz ¸¶À»ÀÇ ±¤Ãµ°ú ºñ½ÁÇÑ ºñµî¼º ¿ÏÇÏÁ¦)
  • Sensurround
    ¼¾¼­¶ó¿îµå(±Í¿¡´Â µé¸®Áö ¾ÊÀ¸³ª ¸öÀ¸·Î Áøµ¿À» ´À³¢°Ô ÇÏ´Â À½Çâ È¿°ú ¹æ¹ý,»óÇ¥)
  • Temin enzyme
    Å׹Πȿ¼Ò(RNA¿¡¼­ DNA¸¦ ¸¸µå´Â ¿ªÀü»ç È¿¼Ò)
  • Uvalue
    U°¡(´Ü¿­ È¿°ú¸¦ ÃøÁ¤Çϴ ôµµ)
  • acoustical cloud
    À½Çâ¹Ý»çÆÇ(¹ÂÁ÷Ȧ µûÀ§ÀÇ À½Çâ È¿°ú¸¦ ³ôÀ̱âÀ§ÇÑ ÀåÄ¡)
  • acoustics
    (Ȧ µîÀÇ)À½ÇâÈ¿°ú ¸í
  • acrosin
    ¾ÆÅ©·Î½Å(Á¤ÀÚÀÇ Ã·Ã¼¿¡ ÀÖ´Â È¿¼Ò)
  • adenosine
    ¾Æµ¥³ë½Å;¸®º¸ÇÙ»êÀÇ È¿¼ÒºÐÇØ¿¡ ÀÇÇÏ¿© ¾ò¾îÁü I
  • aeffect
    ÀÌÈ­ È¿°ú(alienation effect)
  • agehardening
    (ÇÕ±ÝÀÇ)½ÃÈ¿ °æÈ­
  • agonistic
    ³íÀïÀÇ(À» ÁÁ¾ÆÇÏ´Â);½Âº®ÀÇ;È¿°ú¸¦ ³ë¸°;¹«¸®ÇÑ(Æ÷Áî µûÀ§)(°í´ë ±×¸®½ºÀÇ)°æ±âÀÇ
  • albumose
    ¾ËºÎ¸ð½º(¼ÒÈ­ È¿¼Ò ÀÛ¿ëÀ¸·Î ´Ü¹éÁúÀÌ ºÐÇØµÈ °Í)
  • allosteric
    ¾Ë·Î½ºÅ׸¯ÇÑ(È¿¼Ò,´Ü¹éÁú)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á